98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12410491 | PMC |
http://dx.doi.org/10.1016/j.jdcr.2025.07.009 | DOI Listing |
JAAD Case Rep
October 2025
Dermatology Associates of West Texas, Lubbock, Texas.
Skeletal Radiol
March 2025
Department of Radiology, Mayo Clinic, 5777 E Mayo Boulevard, Phoenix, AZ, USA.
Objective: To review the spectrum of clinical and imaging features of glomus tumor involving the musculoskeletal system including the typically solitary forms as well as the rarer multifocal forms (glomuvenous malformation and glomangiomatosis).
Materials And Methods: A retrospective review of our institutional pathology database from 1996 to 2023 identified 176 patients with 218 confirmed glomus tumors. Primary imaging studies included MRI (125), radiographs (100), clinical/intraoperative photos (77), and ultrasound (36).
Dermatol Surg
September 2022
Department of Dermatology, University of Texas McGovern Medical School at Houston, Houston, Texas.
Background: Polidocanol is an FDA-approved treatment of incompetent great saphenous veins, accessory saphenous veins, and visible varicosities of the great saphenous vein system, but numerous other off-label dermatological applications have been reported.
Objective: To describe the various off-label dermatological clinical uses of polidocanol, as well as efficacy and adverse effects.
Methods: The review of studies searchable on PubMed from 2004 to 2021 describing clinical uses of polidocanol to determine efficacy and adverse effects associated with various dermatologic applications.
Cureus
June 2022
Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.